Multi-drug-resistant tuberculosis epidemiology and demographics

Revision as of 17:53, 30 September 2014 by Ammu Susheela (talk | contribs) (→‎Race)
Jump to navigation Jump to search

Multi-drug-resistant tuberculosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multi-drug-resistant tuberculosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Multi-drug-resistant tuberculosis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multi-drug-resistant tuberculosis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multi-drug-resistant tuberculosis epidemiology and demographics

CDC on Multi-drug-resistant tuberculosis epidemiology and demographics

Multi-drug-resistant tuberculosis epidemiology and demographics in the news

Blogs on Multi-drug-resistant tuberculosis epidemiology and demographics

Directions to Hospitals Treating Multi-drug-resistant tuberculosis

Risk calculators and risk factors for Multi-drug-resistant tuberculosis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]

Overview

Epidemiology and Demographics

A 1997 survey of 35 countries found rates above 2% in about a third of the countries surveyed. The highest rates were in the former USSR, the Baltic states, Argentina, India and China, and was associated with poor or failing national Tuberculosis Control programmes. Likewise, the appearance of high rates of MDR-TB in New York city in the early 1990s was associated with the dismantling of public health programmes by the Reagan administration.[1][2]

MDR-TB can develop in the course of the treatment of fully sensitive TB and this is always the result of patients missing doses or failing to complete a course of treatment.

Thankfully, MDR-TB strains appear to be less fit and less transmissible. It has been known for many years that INH-resistant TB is less virulent in guinea pigs, and the epidemiological evidence is that MDR strains of TB do not dominate naturally. A study in Los Angeles found that only 6% of cases of MDR-TB were clustered. This should not be a cause for complacency: it must be remembered that MDR-TB has a mortality rate comparable to lung cancer. It must also be remembered that people who have weakened immune systems (because of diseases such as HIV or because of drugs) are more susceptible to catching TB.

Incidence

  • 3.6 % of the new tubercular cases have multi drug resistant strains.
  • About 20% of the previously treated strains have drug resistance.
  • The frequency of MDR TB varies substancially among countries.
  • 10 % of MDR- TB cases are also resistant to two second line drug classes or XDR (Extensively drug resistant TB)
  • 92 countries have reported atleast oe XDR case by september 2013.
  • About 450 000 people developed MDR-TB in the world in 2012. More than half of these cases were in India, China and the Russian Federation.
  • It is estimated that about 9.6% of MDR-TB cases had XDR-TB.
Image 1-Notified MDR-TB cases (absolute numbers), 2012.png[1][3]
Image 1 -Primary MDR TB, United States, 1993–2013 [http://www.cdc.gov/tb/statistics/surv/surv2013/slides/surv22.htm[4]
Image 2 Primary Anti-TB Drug Resistance - Center for Disease Control and Prevention(CDC)[4]
Primary Isoniazid Resistance in U.S.-born vs. Foreign-born Persons, United States, 1993–2013Adapted from Centers for Disease Control and Prevention.[5]
Primary MDR TB in U.S.-born vs. Foreign-born Persons, United StatesAdapted from Centers for Disease Control and Prevention.[5]
Primary Isoniazid Resistance in U.S.-born vs. Foreign-born Persons, United States, 1993–2013Adapted from Centers for Disease Control and Prevention.[5]

Race

The highest amount of MDR-TB and resistance in United States is found in foreign born population esspecially from Soviet Union with 8.5 % and 33.5% of any resistance of TB in 2000.

Tuberculosis in prison

A rise in multi drug resistant strains of tuberculosis infection is found in prisons of developing countries as well as spanish prison and outbreaks in some prisons in New york city.



References

  1. Frieden TR, Sterling T, Pablos-Mendez A; et al. (1993). "The emergence of drug-resistant tuberculosis in New York City". N Engl J Med. 328 (8): 521&ndash, 56. PMID 8381207.
  2. Laurie Garrett (2000). Betrayal of trust: the collapse of global public health. New York: Hyperion. pp. 268ff. ISBN 0786884407 Check |isbn= value: checksum (help).
  3. "World health organization (WHO)".
  4. 4.0 4.1 "Center for Disease Control and Prevention (CDC)".
  5. 5.0 5.1 5.2 "Public Health Image Library (PHIL), Centers for Disease Control and Prevention".

Template:WH Template:WS